SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-14-175141
Filing Date
2014-05-01
Accepted
2014-05-01 10:12:27
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A d615506ds1a.htm S-1/A 1840258
2 EX-23.1 d615506dex231.htm EX-23.1 1529
3 GRAPHIC g615506g06w83.jpg GRAPHIC 34555
4 GRAPHIC g615506g23p53.jpg GRAPHIC 24046
5 GRAPHIC g615506g30y07.jpg GRAPHIC 39636
6 GRAPHIC g615506g54q25.jpg GRAPHIC 25384
7 GRAPHIC g615506g57i48.jpg GRAPHIC 22171
8 GRAPHIC g615506g65j18.jpg GRAPHIC 47242
  Complete submission text file 0001193125-14-175141.txt   2109807
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-193204 | Film No.: 14802468
SIC: 2834 Pharmaceutical Preparations